Clinical Trial: Moxifloxacin vs. Polytrim for Conjunctivitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Single Blinded Clinical Trial Comparing Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution for Treatment of Conjunctivitis.

Brief Summary: The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.

Detailed Summary:
Sponsor: University of Rochester

Current Primary Outcome: Number of Participants With Normal Physical Examination of the Eye [ Time Frame: 10 days ]

Original Primary Outcome: Clinical Cure [ Time Frame: 10 days ]

Current Secondary Outcome: Number of Participants With a Negative Bacterial Culture [ Time Frame: 10 days ]

Conjunctival swab specimens were inoculated onto tryptic soy agar with 5% sheep blood and GC II agar supplemented with hemoglobin and isovialex with incubation at 35 degrees C in ambient air supplemented with 5% carbon dioxide for 48 hours. S pneumoniae, H influenzai and M Catarrhalis were identified.


Original Secondary Outcome: Microbiological cure [ Time Frame: 10 days ]

Information By: University of Rochester

Dates:
Date Received: December 18, 2007
Date Started: March 2007
Date Completion:
Last Updated: December 11, 2015
Last Verified: December 2015